Facile Synthesis of Rigid Binuclear Manganese Complexes for Magnetic Resonance Angiography and SLC39A14-Mediated Hepatic Imaging.

Manganese(II)-based contrast agents (MBCAs) are potential candidates for gadolinium-free enhanced magnetic resonance imaging (MRI). In this work, a rigid binuclear MBCA (Mn 2 -PhDTA 2 ) with a zero-length linker was developed via facile synthetic routes, while the other dimer (Mn 2 -TPA-PhDTA 2 ) with a longer rigid linker was also synthesized via more complex steps. Although the molecular weight of Mn 2 -PhDTA 2 is lower than that of Mn 2 -TPA-PhDTA 2 , their T 1 relaxivities are similar, being increased by over 71% compared to the mononuclear Mn-PhDTA. In the presence of serum albumin, the relaxivity of Mn 2 -PhDTA 2 was slightly lower than that of Mn 2 -TPA-PhDTA 2 , possibly due to the lower affinity constant. The transmetalation reaction with copper(II) ions confirmed that Mn 2 -PhDTA 2 has an ideal kinetic inertness with a dissociation half-life of approximately 10.4 h under physiological conditions. In the variable-temperature 17 O NMR study, both Mn-PhDTA and Mn 2 -PhDTA 2 demonstrated a similar estimated q close to 1, indicating the formation of monohydrated complexes with each manganese(II) ion. In addition, Mn 2 -PhDTA 2 demonstrated a superior contrast enhancement to Mn-PhDTA in in vivo vascular and hepatic MRI and can be rapidly cleared through a dual hepatic and renal excretion pattern. The hepatic uptake mechanism of Mn 2 -PhDTA 2 mediated by SLC39A14 was validated in cellular uptake studies.